Combining medical treatment and CBT in treating alcohol-dependent patients: Effects on life quality and general well-being

Alcohol and Alcoholism

Volumn 48, Issue 6, 2013, Pages 687-693

  Laaksonen, E ^a   Vuoristo Myllys, S ^b,c   Koski Jannes, A ^d   Alho, H ^b,c  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; DISULFIRAM; NALTREXONE; DRUGS USED IN THE TREATMENT OF ADDICTION; TAURINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRINKING BEHAVIOR; FEMALE; FOLLOW UP; HELP SEEKING BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; MULTICENTER STUDY; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SLEEP; SMOKING HABIT; TREATMENT OUTCOME; WELLBEING; AFFECT; ANALOGS AND DERIVATIVES; ANXIETY; CLINICAL TRIAL; COMPLICATION; INDIVIDUALITY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEUROPSYCHOLOGICAL TEST; PATIENT COMPLIANCE; PROCEDURES; PSYCHOLOGY; SMOKING; STATISTICAL MODEL; YOUNG ADULT;

ADULT; AFFECT; AGED; ALCOHOL DETERRENTS; ALCOHOLISM; ANXIETY; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSION; DISULFIRAM; FEMALE; HUMANS; INDIVIDUALITY; LOGISTIC MODELS; MALE; MIDDLE AGED; NALTREXONE; NEUROPSYCHOLOGICAL TESTS; PATIENT COMPLIANCE; QUALITY OF LIFE; SMOKING; TAURINE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84886232947     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agt053     Document Type: Article

References (40)

1. Baltieri DA, Daro FR, Ribeiro PL et al. (2009) Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients. Drug Alcohol Depend 105:33-41.
2. Batel P, Pessione F, Maitre C et al. (1995) Relationship between alcohol and tobacco dependencies among alcoholics who smoke. Addiction 7:977-80.
3. Beck AT, Steer RA. (1984) Internal consistencies of the original and revised Beck Depression Inventory. J Clin Psychol 40:1365-7.
4. Beck A, Ward C, Mendelsson M et al. (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-71.
5. Bobo J. (1992) Nicotine dependence and alcoholism epidemiology and treatment. J Psychoactive Drugs 24:123-9.
6. Brown RA, Evans DM, Miller IW et al. (1997) Cognitive-behavioral treatment for depression in alcoholism. J Consult Clin Psychol 65:715-26.
7. Burling T, Ziff D. (1988) Tobacco smoking: a comparison between alcohol and drug abuse inpatients. Addict Behav 13:185-90.
8. Crum R, Storr C, Chan Y et al. (2004) Sleep disturbance and risk for alcohol-related problems. Am J Psychiatry 161:1197-203.
9. Curran G, Flynn H, Kirchner J et al. (2000) Depression after alcohol treatment as a risk factor for relapse among male veterans. J Subst Abuse Treat 19:259-65.
10. Donovan D, Mattson ME, Cisler RA et al. (2005) Quality of life as an outcome measure in alcoholism treatment research. J Stud Alcohol 15:119-39.
11. Driessen M, Meiner S, Hill A et al. (2001) The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol Alcohol 36:249-55.
12. EuroQol Group. (1990) EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 16:199-208.
13. Frischknecht U, Sabo T, Mann K. (2013) Improved drinking behaviour improves quality of life: a follow-up in alcohol-dependent subjects 7 years after treatment. Alcohol Alcohol. http://alcalc.oxfordjournals.org/content/early/2013/04/29/alcalc.agt038.full. [Epub ahead of print].
14. Fucito LM, Aesoon P, Gulliver SB et al. (2012) Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence. Biol Psychiatry 72:832-8.
15. Grant BF, Hasin DS, Chou SP et al. (2004) Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 61:1107-15.
16. Hasin DS, Stinson FS, Oqburn E et al. (2007) Prevalence, correlates, disability and comorbidity of DSM-AV alcohol abuse and dependence in the United States. Arch Gen Psychiatry 64:830-42.
17. Hertling I, Ramskogler K, Dvorak A et al. (2005) Craving and other characteristics of comorbidity of alcohol and nicotine dependence. Eur Psychiatry 5-6:442-50.
18. Hodgins DC, Dufour M, Amstrong S. (2000) The reliability and validity of the inventory to diagnose depression in alcohol-dependent men and women. J Subst Abuse 11:369-78.
19. Holt LJ, Litt MD, Cooney NL. (2012) Prospective analysis of early lapse to drinking and smoking among individuals in concurrent alcohol and tobacco treatment. Psychol Addict Behav 26:561-72.
20. Koskenvuo M. (1997) The Finnish twin registry baseline characteristics. National Institute for Health and Welfare. University of Helsinki.
21. Laaksonen E, Koski-Jännes A, Salaspuro M et al. (2008a) A randomized, multicentre, openlabel, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 43:3-61.
22. Laaksonen E, Koski-Jännes A, Salaspuro M et al. (2008b) Winning at last-defeating the drinking problem. Alcohol Alcohol 43:53-61. http://alcalc.oxfordjournals.org/cgi/content/full/agm136/DC1.
23. Mikkonen A. (2007) Samanaikainen alkoholiongelman ja masennuksen varhainen tunnistaminen ja hoito parantavat ennustetta. Suomen Lääkärilehti 51-52 62:4747-50.
24. Mueller SE, Petitjean SA,Wiesbeck GA. (2012) Cognitive behaviour smoking cessation during alcohol detoxification treatment: a randomized, controlled trial. Drug Alcohol Depend 126:279-85.
25. Muhonen L, Lönnqvist J, Juva K et al. (2008) Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. J Clin Psychiatry 69:392-9.
26. Musacchio JM, Goldenstein M, Anagnoste B et al. (1966) Inhibition of dopamine-ß-hydroxylase by disulfiram in vivo. J Pharmacol Exp Ther 152:56-61.
27. O'Donnel K,Wardle J, Dantzer C et al. (2006) Alcohol consumption and symptoms of depression in young adults from 20 countries. J Stud Alcohol 67:837-40.
28. O'Dowd A. (2006) Tobacco and alcohol should be classed as dangerous drugs. BMJ 333: news 275.
29. O'Malley SS, Cooney JL, Krishnan-Sarin S et al. (2006) A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation. Arch Intern Med 27:667-74.
30. Paykel E, Priest R. (1992) Recognition and management of depression in general practice: consensus statement. BMJ 305:1198-202.
31. Perney P, Lehert P, Mason BJ. (2012) Sleep disturbance in alcoholism: proposal of a simple measurement, and results from a 24-week randomized controlled study a alcohol-dependent patients assessing acamprosate efficacy. Alcohol Alcohol 47:133-9.
32. Peters TJ, Millward LM, Foster J. (2003) Quality of life in alcohol misuse: comparison of men and women. Arch Womens Ment Health 6:239-43.
33. Pilling S, Yesufu-Udechuku A, Taylor C et al. (2011) Diagnosis, assessment, and management of harmful drinking and alcohol dependence: summary of NICE guidance. BMJ 342:d700.
34. Poikolainen K, Karkkainen P. (1983) Diary gives more accurate information about alcohol consumption than questionnaire. Drug Alcohol Depend 11:209-16.
35. Salokangas RK, Poutanen O, Stengård E. (1995) Screening for depression in primary care. Development and validation of the Depression Scale, a screening instrument for depression. Acta Psychiatr Scand 92:10-6.
36. Schuckit MA. (1986) Genetic and clinical implications of alcoholism and affective disorder. Am J Psychiatry 143:140-7.
37. Scott J, Huskinsson E. (1976) Graphic representation of pain. Pain 2:175-84.
38. Starosta A, Leeman R, Volpicelli J. (2006) The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders. J Psychiatr Pract 12:80-7.
39. Thase ME, Salloum IM, Cornelius JD. (2001) Comorbid alcoholism and depression: treatment issues. J Clin Psychiatry 62: 32-41.
40. Von Bardeleben U, Knoch H, Ihde T et al. (1999) Randomized open efficacy study of naltrexone vs acamprosate vs disulfiram combined with cognitive-behavioral psychotherapy in preventing alcohol relapse. In Ladewig D (ed). Basic and Clinical Science of Substance Related Disorders. Basel: Karger, 45-8.